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From the Editor 
The Bleeding Edge 
Almost four years ago, I was intrigued by a very incisive and provocative editorial1 in 
the Wall Street Journal by J. D. Kleinke, a noted healthcare economist. The editorial 
spoke of an industrial revolution coming to medicine based on a rationalization of the 
haphazard use of services, an improvement in quality, and a reduction in costs. Now, 
the same author has written a new book entitled, The Bleeding Edge,2 published 
recently by Aspen Publishers. I thought our readership would be interested in his 
detailed thesis about the future, focused on the ascendancy of a new business entity 
in health care, the EHO—the Emerging Healthcare Organization. 
 
The central thesis of this fascinating book is that five key forces will culminate in the 
transformation of the health care industry to a world of EHOs characterized by 
decreased costs, an increase in quality, and the "liberation" of physicians from the 
perceived bonds of managed care. Let me first note these five forces and define 
them; then, we will explore Kleinke’s vision for each of these forces in turn. The key 
question that Kleinke addresses is, "How do we transform 15% of the world’s largest 
economy?" The interaction among these five forces provides the driving energy for 
the transformation. The five forces include risk assumption, consumerism, 
consolidation, integration, and ultimately industrialization. These five forces will 
create a post-managed care organization world with the inevitable demise of the 
national managed care companies that we know today. The managed care company 
of the future will become only a middle-market health plan reduced to sales, 
marketing, and reinsurance functions only. Over time, according to Kleinke, EHOs 
will eventually "develop the critical mass and organization sophistication necessary to 
assume financial risk, thereby industrializing their processes of care to manage this 
risk in a profitable way" in a nutshell, a complete transformation of the healthcare 
economy. Let’s review these five forces in turn. 
 
Risk assumption will correct the fundamental problems in healthcare consumption 
and market economics. Kleinke contends that through risk assumption or capitation 
physicians and hospitals will be required to act like all other free-market producers of 
goods who are motivated to focus not only on maximizing revenues but also on the 
cost of the goods sold. He specifically contends that capitation will force us to 
confront the reality that physicians are self-interested economic agents—surely, a 
provocative viewpoint. Capitation, then, becomes the vehicle for "provider liberation" 
by eliminating the middleman and guaranteeing provider ascendancy in this New 
World Order of the EHO. As the role of the managed care organization becomes 
increasingly marginalized, one simple truth emerges in Kleinke’s vision that "in the 
new century’s healthcare system, the only transactions left will be the transfer and 
assumption of medical/financial risk." 
 
The second force, consumerism, will neutralize distortions in the healthcare system 
created by the self-interest and faulty paternalism of managed care organizations 
and other insurers. Consumerism will correct the "asymmetries of information" by 
providing consumers with information for more informed decision-making. It will also 
engender the branding of healthcare services. Both topics have been covered in this 
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column previously ("Consumerism in Health Care," September 1998 [Vol. 11, No. 
3]).  
 
The third force, consolidation, will rescale the healthcare infrastructure properly, 
mobilize capital, spread risk across broader populations of patients and providers, 
and allocate healthcare resources more efficiently. Essentially, this section of the 
book repeats his key theme that healthcare is transforming itself into a business, no 
less exempt from the laws of competition than automobiles or the airline industry. 
Why are managed care organizations like Aetna U.S. Healthcare purchasing 
Prudential and NYLCare? According to Kleinke, its nothing but the law of large 
numbers. They are attempting to create larger risk pools to better absorb larger 
losses. Bigger is less risky. But Kleinke contends that this is their "only structural 
competitive advantage" against the fundamental economic challenge posed by what 
he calls "forward integration of providers." Translation: the managed care companies 
can get bigger and bigger but, eventually, the elimination of the middleman will 
occur if providers are able to integrate and industrialize their processes. 
 
Integration, the fourth force, corrects the fragmentation and other structural defects 
built into the medical delivery system. Kleinke calls this the end of "clinical 
apartheid"—meaning that those decisions with the greatest impact on the 
institution’s cost and profits, and the quality of the care delivered, are made by a 
class of people not usually employed by that institution. Of course, he speaks here of 
physicians. Integration and integrated delivery systems are, themselves, better able 
to systematically study how to improve the process of care. As provider information 
systems mature and go beyond simple intermediate measures, like length-of-stay 
and the cost of prescriptions, we will enter the integration stage where the true 
endpoints for measurement, like total costs and final outcomes (across the 
continuum of care), will be quantifiable. Integration, then, becomes inextricably 
linked to quality improvement, better information systems, better understanding of 
the processes, and improved ability to change those processes. Simply put, 
integration is the gateway to the final force of industrialization. 
 
The fifth force, industrialization, according to Kleinke, is the stage where we 
rationalize the haphazard use of services, increase economic predictability, improve 
quality, and reduce costs. This might sound familiar to our newsletter readers 
("Higher Quality at Lower Cost?" January 1999 [Vol. 12, No. 1]). Industrialization 
means that providers will bring to an end unexplained clinical variation and 
neutralize unnecessary heterogeneity in the processes we use to care for patients. 
The richness of the clinical data available to us will become our critical strategic 
advantage for the future, eclipsing the claims-based data left available to the 
insuring organizations. Finally, we will obtain the greatest paradox of all, according 
to Kleinke, in that "physicians will be driven by their own financial self-interest to 
create and support systems that measure their own performance, reduce variability, 
and promote treatment paths where they, themselves, are the providers of last 
resort." 
 
Certainly, this book may not appeal to everyone. Yet the theme, as articulated 
through these five forces, is an engaging hypothesis worthy of our discussion and 
debate. Kleinke has asked some critical questions and put forward his own well-
supported views about the transformation of the business of healthcare into the next 
century. Perhaps he will begin a more focused national provider-driven debate on 
these salient issues. Selfishly, I would like to continue the discussion and I am, as 
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usual, interested in your views. Kleinke can be reached directly at his Web Site: 
http://www.hs-net.com.
- David B. Nash, MD, MBA  
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